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Recognition of infections with human metapneumo-
virus (HMPV) among institutionalised elderly is rising. 
When HMPV was found to be the causative agent of 
an outbreak of pneumonia in a residential care facility 
for elderly in the Netherlands, an elaborate outbreak 
investigation was set up, including active surveillance 
for new cases. From clinical cases, defined by fever (> 
38°C) and symptoms of respiratory tract infections, 
respiratory samples for analyses of viral pathogens 
by real-time Reverse Transcriptase Polymerase Chain 
Reaction (rRT-PCR) and blood samples for determina-
tion of HMPV-specific IgM and IgG antibody titres were 
taken. Five staff members and 18 residents fulfilled the 
clinical case definition. Of those, five residents tested 
positive for HMPV by rRT-PCR. The combination of rRT-
PCR and serology identified nine confirmed cases, six 
probable cases, six possible cases and ruled out two 
persons as cases. Among residents, the outbreak of 
HMPV had an attack rate, ranging from 5% for labo-
ratory-confirmed cases, to 13% for clinical cases. This 
outbreak investigation shows that HMPV is a potential 
serious pathogen for institutionalised elderly.
Introduction
Outbreak description
In mid-February 2010, staff of a residential care facil-
ity for the elderly notified an outbreak of pneumonia 
to the municipal health service of the town of Utrecht, 
the Netherlands. At the time, in five weeks, nine of the 
140 residents and two staff members had fallen ill with 
pneumonia. Three residents had been admitted to the 
hospital. One resident was admitted with cardiac fail-
ure and pneumonia, another with dyspnoea (oxygen 
dependent) due to a lower respiratory tract infection 
(RTI) (X-ray: possible lobar infiltrate) and the third resi-
dent was admitted among other things because of a 
deteriorating lower RTI (X-ray: lobar infiltrate). All three 
died in the hospital shortly after admission. No viro-
logical examination had been performed and a defi-
nite causative agent was not established for any of the 
three deceased patients. The other ill residents were 
not admitted to hospital but treated by general prac-
titioners in the care facility, mostly with antibiotics. 
Although RTIs can be expected in winter season, the 
clinical presentation – especially the three deaths with 
a possible common causative agent – together with the 
number of cases, were found severe enough to justify 
an outbreak investigation.
This induced an inventory of clinical cases (onset of 
disease, symptoms, clinical diagnosis, treatment, 
date of birth and sex) and the active surveillance for 
new clinical cases among residents and staff members 
in this facility, from mid-February onwards. A clinical 
case was defined by fever (> 38˚C) and clinical symp-
toms of RTI. Respiratory samples for analyses of viral 
pathogens were taken from three new clinical cases, 
five days after the initial notification. When laboratory 
investigations on 23 February 2010 identified human 
metapneumovirus (HMPV) as causative agent, an elab-
orate outbreak investigation among staff and residents 
was set up.
Residents, staff members and the general practitioners 
of the residents were informed about the outbreak and 
infection control measures were taken. These included: 
(i) isolation of the ill residents in their own apartments 
until symptoms resolved, (ii) use of a surgical mask 
by staff members while giving care to the ill residents 
as well as application of strict hand hygiene, (iii) all 
persons – staff members, family members, and other 
visitors - leaving the apartment of ill residents were 
advised to apply hand alcohol.
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These measures were lifted on 15 March 2010 after 
two maximum incubation periods (12 days) without the 
occurrence of new clinical cases.
Background on human metapneumovirus
HMPV is a respiratory pathogen, which was first iden-
tified in 2001 in children with RTI [1]. It is a single-
stranded RNA virus with a lipid envelope and belongs to 
the family Paramyxoviridae, subfamily Pneumovirinae. 
Phylogenetic analysis has identified two subgroups 
of HMPV, subgroups A and B, and two clades within 
each of these subgroups [2]. Seroprevalence data sug-
gest that most children are infected by the age of five 
and re-infection occurs throughout life [1,3,4]. Most 
infections occur during late winter and early spring 
[4]. Depending on the region of the world, both HMPV 
subgroups A and B may co-circulate, but during an epi-
demic one subtype usually dominates [5]. Transmission 
is likely by direct (e.g. via hands) or close contact (e.g. 
via coughing or sneezing) with contaminated secre-
tions, which may involve large particle aerosols, drop-
lets or saliva. The clinical incubation period is not 
precisely known; estimates range from three to six 
days [6]. Clinical manifestations of HMPV infection are 
similar to those of respiratory syncytial virus (RSV). 
The majority of HMPV infections are self-limiting mild 
upper RTI, but in a minority it causes lower RTI such 
as bronchiolitis and pneumonia, requiring occasionally 
mechanical ventilation support. Risk factors for severe 
HMPV infections are age (< 5 years and > 65 years of 
age), compromised immune status and underlying 
pulmonary or cardiac disease [7,8]. Treatment is sup-
portive and varies with the clinical manifestations. 
Ribavirin and polyclonal intravenous immune globu-
lin (IVIG) are active against HMPV in vitro and reduce 
viral replication in experimentally infected mice, but 
clinical data on the effectiveness in humans are lack-
ing [9,10]. Since the discovery of HMPV the majority of 
clinical publications concerns infections in children, 
but the number of publications on outbreaks of HMPV 
infections in institutionalised adults and elderly is ris-
ing [11-15]. However, no studies have been performed 
combining results of real-time Reverse Transcriptase 
Polymerase Chain Reaction (rRT-PCR) and serology dur-
ing outbreaks.
This article describes an outbreak of HMPV in a resi-
dential care facility for elderly, in which a combined 
approach of epidemiology and laboratory investiga-
tions (rRT-PCR and serology) gave insight in the extent 
of HMPV infection.
Methods
Laboratory investigation
Respiratory samples for viral analysis were taken from 
each new clinical case. Sampling consisted of a nasal 
swab and a pharyngeal swab which were transported 
to the laboratory in one viral transport medium (univer-
sal transport medium (UTM)). Viral analysis was per-
formed with rRT-PCR.
Sampling new clinical cases for viral analysis contin-
ued until the outbreak was ended on 15 March 2010. 
Furthermore, cases positive for HMPV were periodi-
cally sampled until the last respiratory sample tested 
negative for HMPV, with a sampling interval of approxi-
mately eight days.
The initial viral analysis by rRT-PCR was performed 
by the laboratory of one of the local hospitals. In a 
later stage, all respiratory samples were analysed in 
one batch by the Erasmus Medical Centre, Rotterdam, 
which is one of the two national reference laboratories 
for respiratory viruses.
After viral DNA or RNA isolation from nasopharyngeal 
swab supernatant, a multiplex rRT-PCR respiratory 
virus panel was used to identify viruses (HMPV, RSV 
types A and B, rhinovirus, parainfluenza virus 1-3, ade-
novirus and influenza A and B viruses) as previously 
described [16-19].
To culture HMPV, it was propagated as described pre-
viously [8]. LLC-MK2 cells (monkey kidney cells, ATCC 
CCL-7) at 80–90% confluency were inoculated in culture 
medium supplemented with trypsin. Subsequently, 
each following day, cells were monitored for cytopatho-
genic effect and harvested when maximum cytopathic 
effect was observed. All isolations were performed 
in duplicates. Viral RNA was extracted, amplified by 
RT-PCR, sequenced and run on an ABI genetic analyser 
as described before with slight modifications [20].
To gain insight into the magnitude of the outbreak, all 
clinical cases – i.e. all clinical cases before and after 
outbreak notification – were requested to donate a 
blood sample for determination of HMPV-specific 
immunoglobulin (Ig) M and IgG antibody titres. A sec-
ond sample was requested from the symptomatic staff 
members. Residents were requested to provide a sec-
ond sample only if a HMPV infection was not probable 
or proven by the results of rRT-PCR or serology from 
the first sample.
HMPV-specific IgM and IgG antibody titres were deter-
mined using the direct immunofluorescent-antibody 
(IFA) test as described before [4,5]. Data are expressed 
as reciprocal anti-HMPV IgM and IgG antibody titres. 
All serological analyses were performed in duplicates. 
An anti-HMPV IgM antibody titre of 64 or higher was 
considered proof of HMPV infection. The same holds 
for a fourfold increase in anti-HMPV IgG antibody titres 
between the first and second blood sample taken (sero-
conversion). An isolated HMPV IgG titre of 256 or above 
was considered indicative of a recent HMPV infection.
Final case classification
Results of both analyses were combined into a final 
case classification for clinical cases: no proof of HMPV 
infection (serology and rRT-PCR negative), possible 
(insufficient laboratory investigations), probable (IgG 
titre first blood sample 256 or above), and confirmed 
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HMPV infection (rRT-PCR positive or IgM first blood 
sample positive (IgM titre 64 or above) or seroconver-
sion (fourfold increase in anti-HMPV IgG antibody titres 
between the first and second blood sample taken).
Results
Outbreak
In all, 23 persons were included in the outbreak investi-
gation: five staff members (one male, four female) and 
18 residents (five male, 13 female). Mean ± Standard 
Deviation (SD) (minimum–maximum) age for staff mem-
bers and residents, was 47.6 ± 3.6 (37–59) and 90.1 ± 
1.1 (83–98) years respectively. Underlying conditions 
of the cases are shown in Table 1.
Among the residents, there was no clustering of cases 
in wards or floors as they were scattered over 10 of the 
12 floors of the residential care facility. Staff members 
were not only nursing staff. Twelve persons had an 
onset of disease after 17 February 2010 and therefore 
respiratory samples were taken. Among the new clini-
cal cases, another two residents were hospitalised; 
one because of the seriousness of the RTI, the other 
because of another medical condition. Both were dis-
charged in an improved condition after about 12 days. 
However, one patient died eventually.
Figure 1 shows the epidemic curve of the outbreak, as 
well as the timeline of outbreak management.
Real-time Reverse Transcriptase 
Polymerase Chain Reaction results
Five of 12 respiratory samples, which were all from res-
idents, tested positive for HMPV by rRT-PCR. Follow-up 
by rRT-PCR was possible for four residents: nose and 
throat swabs were obtained with an interval of approxi-
mately eight days until a sample tested negative. As 
shown in Figure 2, these residents shedded HMPV for 
at least nine to 17 days after onset of disease.
rRT-PCR results of both laboratories were consist-
ent (Pearson’s r between the cycle threshold values 
(Ct-values) is 0.94, p<0.001, nine samples). There was 
a clear correlation between the Ct-values and the time 
from disease onset: the longer the period between 
onset of disease and respiratory sampling, the higher 
the Ct-value (Figure 3, R2 linear = 0.39, p<0.04, 11 sam-
ples), indicating lower virus levels with time.
The virus was isolated from one respiratory sample 
from HMPV positive patient 3 (Figure 2). HMPV geno-
type A was assigned based on submission of the glyco-
protein (G) gene sequence to a BlastN search (Genbank 
accession JN200816).
Figure 1
Epidemic curve and outbreak management, outbreak of human metapneumovirus in a residential care facility for elderly in 
Utrecht, the Netherlands, January–March 2010
HMPV: human metapneumovirus.
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Table 1
Underlying conditions in clinical cases, outbreak of 
human metapneumovirus in a residential care facility for 
elderly in Utrecht, the Netherlands, January–March 2010 
(n=23)
Underlying condition Number of cases
Cardiac diseasea 14
Cardiac failurea 6
Atrial fibrillationa 3
Angina pectorisa 2
Chronic obstructive pulmonary diseasea 3
Hypertension 4
Cerebro vascular attacka 5
Transient ischemic attacka 3
Diabetes mellitusa 4
Renal failurea 1
Hypothyroidisma 1
Asthmab 2
a Underlying condition only in residents of the care facility for 
elderly.
b Underlying condition only in staff of the care facility for elderly.
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Serological results
The first serum sample was taken at a median of 23 
days after onset of disease (range: 11–63, n=18). The 
second sample was taken at a median of 64 days after 
onset of disease (range: 59–113, n=9). As at that time, 
the HMPV genotype was unknown, both HMPV A and 
HMPV B infected LLC-MK2 cells were used to deter-
mine the antibody titres. As sequencing showed it 
was HMPV genotype A, only HMPV A-specific antibody 
titres are shown (Table 2). The titres of HMPV genotype 
B were similar or one step deviant from the titres of 
HMPV genotype A.
One of 18 clinical cases showed a positive HMPV-
specific IgM antibody titre in the first serum sample; 
this case still had a positive IgM in the second sample. 
Anti-HMPV IgG antibody titres in both first and second 
sample were indicative of recent HMPV infection for six 
clinical cases. Seroconversion occurred in seven sera 
of nine persons tested twice (Table 2).
Final case classification
Table 2 shows the rRT-PCR and serological results as 
well as the final case classification of the 23 clinical 
cases. As the rRT-PCR results already identified five 
confirmed cases, the serological results increased that 
number to nine. Based on IgG level in the first serum 
sample, another six clinical cases could be classi-
fied as probable cases. The majority of the confirmed 
(seven of nine cases) and all probable cases (six cases) 
were residents. Nevertheless, the diagnostic approach 
identified two staff members as confirmed cases as 
well. For two clinical cases, both diagnostic results 
excluded a HMPV infection. Figure 4 summarises the 
results of the outbreak investigation.
Figure 4. Flowchart of the laboratory investigations 
and results, outbreak of human metapneumovirus in 
a residential care facility for the elderly, Utrecht, the 
Netherlands, January–March 2010
Given the numbers of possible, probable and con-
firmed cases, the attack rate of HMPV infection among 
residents in this outbreak was 5% for laboratory-con-
firmed cases (seven confirmed cases of 140 residents) 
and 13% for clinical cases (18 possible, probable and 
confirmed cases of 140 residents).
Discussion
This article describes an outbreak of HMPV in a residen-
tial care facility for elderly. Notifications of outbreaks 
of pneumonia in these kind of facilities for elderly are 
not very common in the Netherlands and HMPV as 
causative agent has not been described earlier.
Five of the 12 (42%) clinical cases, occurring after the 
outbreak was notified and from whom respiratory sam-
ples were taken, tested positive for HMPV by rRT-PCR. 
Our results are in agreement with those of Boivin et 
al., who, upon investigating a HMPV outbreak in a long 
term care facility in Canada, found six of 13 tested resi-
dents (46%) HMPV positive by rRT-PCR [11]. In a sum-
mer outbreak in a long term care facility in California, 
however, a lower proportion was found, with five of 
20 cases (25%) testing HMPV positive by RT-PCR [13]. 
Higher proportions than in our study are neverthe-
less also reported concerning two other outbreaks 
where RT-PCR was used. In a hospital for older people 
in Japan, Honda et al. found that all eight inpatients 
(100%) in the same day-care room were RTI HMPV posi-
tive, while Tu et. al. found 10 of 13 patients (77%) HMPV 
positive, in a psychiatric ward of an armed-forces gen-
eral hospital in Taiwan [12,15]. All studies included 
relatively small numbers of patients ranging from eight 
to 18 patients. The differences in proportions might 
partly be explained by the different settings (residen-
tial care facilities for elderly versus hospital settings). 
On the other hand, in this outbreak investigation we 
Figure 2
Follow-up of four human metapneumovirus positive cases, 
outbreak of human metapneumovirus in a residential care 
facility for elderly in Utrecht, the Netherlands, January–
March 2010
HMPV: Human metapneumovirus.
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sampled only staff and residents fulfilling the clinical 
case definition. Asymptomatic cases and less severe 
cases are therefore missed.
Follow-up respiratory samples showed that viral RNA 
remained detectable in residents during a relatively 
long period after disease onset, ranging from at least 
nine to 17 days. Whether this correlates with transmis-
sion of the virus is unknown. Because outbreak control 
measures were taken, the absence of new cases could 
not be used as a parameter for this. Alternatively, virus 
isolations by culture could be used as a surrogate 
parameter. However, isolation of HMPV by culture is 
relatively difficult due to its slow growth and mild cyto-
pathic effects. Since viral culture remained negative in 
follow-up samples, it is possible that non-infectious 
viral particles/RNA fragments in cell debris from the 
lower lungs, could explain the positive rRT-PCR results 
in the follow-up samples.
We took infection control measures similar to those 
taken in case of RSV infection: clinical cases were 
cared for in isolation until clinical recovery and strict 
hand hygiene was applied. This approach seems jus-
tified given the probability of a relative long period 
of viral shedding. Also, after control measures were 
taken, new clinical cases only occurred in the follow-
ing week, while they occurred during five weeks before 
the outbreak was notified. This is shorter than Boivin 
et al. reported [11]. In the later outbreak only droplet- 
and contact precautions were taken and new cases 
occurred for at least two weeks.
When serological results were combined with rRT-
PCR results, four additional confirmed cases of HMPV 
infection and six probable cases were identified. The 
differences between rRT-PCR and serological results 
might be explained in various ways. Most likely, timing 
of sampling relative to onset of disease could explain 
these findings. Alternatively, sampling error or vari-
ations in the time of viral shedding might play some 
role. Possibly, more cases could have been confirmed 
as the sensitivity and specificity to detect IgM and IgG 
antibody titres with fixed and permeabilised infected 
cell monolayers is lower compared to enzyme-linked 
immunosorbent assay (ELISA), but HMPV ELISAs for 
both IgM and IgG were not in use as a diagnostic tool. 
Nevertheless, it is clear that a combined approach of 
serology and rRT-PCR has added diagnostic value.
For the early stage of an outbreak, serology by itself 
cannot be used as the interval between virus spreading 
Table 2
Final case classification and laboratory results of clinical cases, outbreak of human metapneumovirus in a residential care 
facility for elderly in Utrecht, the Netherlands, January–March 2010 (n=23)
Case Final caseclassification
HMPV rRT-PCR
Ct-value
First serum sample 
Reciprocal IgG antibody titre
Second serum sample
Reciprocal IgG antibody titre
1 Confirmed 26a <16 256
2 Confirmed 33 <16 (IgM 256) 1,024
3 Confirmed 36 <16 1,024
4 Confirmed 33 <16 Deceased
5 Confirmed 38 <16 ND
6 Confirmed Negative <16 1,024
7 Confirmed Negative <16 512
8 Confirmed Negative <16 256
9 Confirmed Negative <16 64
10 Probable ND >1,024 ND
11 Probable ND >1,024 ND
12 Probable ND >1,024 ND
13 Probable ND 256 ND
14 Probable ND 256 ND
15 Probable Negative 256 ND
16 Possible Negative 16 ND
17 Possible Negative Sample not provided Sample not provided
18 Possible Sample not provided Sample not provided Sample not provided
19 Possible Deceased Deceased Deceased
20 Possible Deceased Deceased Deceased
21 Possible Deceased Deceased Deceased
22 Non-case ND 64 16
23 Non-case ND 16 16
ND: not determined; HMPV: Human metapneumovirus; rRT-PCR: real-time Reverse Transcriptase Polymerase Chain Reaction.
a Viral culture positive.
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and detection of HMPV-specific IgM and IgG antibodies 
is too long to manage the outbreak, especially consid-
ering immunosenescence in elderly [20]. Based on the 
present data, we would recommend a combined diag-
nostic approach, in which a direct IFA test is coupled to 
rRT-PCR. IFA is a rapid and useful test for the diagnosis 
of HMPV infections in outbreaks. However, the sensi-
tivity of IFA is lower than that of rRT-PCR and needs to 
be validated before use [21]. While the results of the 
IFA, available within two hours, are validated by rRT-
PCR, appropriate measures can be taken. Furthermore, 
standardised timing of sample collection (time after 
onset of disease, time intervals between samples) for 
serology clearly contributes to the final identification 
of cases in outbreak studies.
This outbreak exemplifies that HMPV can cause severe 
disease. The majority of the resident cases were 
treated for pneumonia and some of them were admit-
ted to the hospital. Several studies have reported 
mortality among elderly due to HMPV [3,11,15,22]. 
Although none of the probable or confirmed HMPV resi-
dent cases in this outbreak died because of the HMPV 
infection, it is very likely that HMPV caused or contrib-
uted to the death of at least one of the three possible 
resident cases that were admitted to hospital and died 
there before the outbreak was notified. After all, the 
grand majority of the resident cases with laboratory 
results turned out to be probable or confirmed HMPV 
cases (13 of 14 clinical cases), making it highly prob-
able that at least one of the three clinical cases, who 
were admitted to hospital and died there before the 
outbreak was notified, had a HMPV infection too.
A further question is how the virus was spread. As 
both residents and staff members were affected, both 
groups could have transmitted the virus to others. 
Direct spread among residents is not very likely as they 
all have their own apartment, but it cannot be ruled 
out as they do share common facilities. Staff members, 
on one hand, could have easily transmitted the virus 
as they do work over all floors, but on the other hand 
they form a small minority under the (probable or con-
firmed) final cases. Another possibility is that affected 
staff members who did not fulfil the clinical case defi-
nition (especially the fever criterion) were involved in 
the transmission, since symptoms of HMPV infection 
are dependent on age and health of the host. It is there-
fore possible that staff members – (much) younger and 
healthier compared to residents - were infected with 
HMPV, but developed only minor symptoms and con-
tinued to work and in doing so, could have spread the 
virus. Whether this hypothesis holds, can only be stud-
ied in an outbreak in which not only persons fulfilling 
the clinical case definition are included, but (a sample 
of) those not fulfilling that definition as well.
In conclusion, this article describes an outbreak of 
HMPV in a residential care facility for elderly with an 
attack rate of 5–13% among residents, with severe dis-
ease and probable mortality. It is of interest that fol-
low-up of rRT-PCR positive cases suggests a relatively 
long period of viral shedding. This should be consid-
ered when applying infection control measures. 
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